Lincoln Pharmaceuticals Limited (LINCOLN)
₹565.5
INR+2.40(+0.43%)
As of June 27, 2025 9:39:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹1138.69 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹921.80 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
13.84
Forward P/E
Price to Earnings ratio based on forecasted earnings
NA
PEG Ratio
Price/Earnings to Growth ratio
-1.18
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
1.83
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
52.34%
Operating Margin
Operating income as a percentage of revenue
13.97%
Return on Equity
Net income as a percentage of shareholders' equity
13.02%
Revenue (TTM)
Total revenue over trailing 12 months
₹623.23 Cr+18%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹123.97 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹41.09-37.8%
Balance Sheet
Total Cash
Total cash and short-term investments
₹196.15 Cr
Total Debt
Total short-term and long-term debt
NA
Debt to Equity
Total debt as a percentage of shareholders' equity
0.00%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹499 - ₹979.5
Beta
Measure of stock's volatility compared to the market
0.31
Shares Outstanding
Total number of shares issued by the company
₹2.00 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
109.99%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
27.50%
Payout Ratio
Percentage of earnings paid as dividends
4.38%
